Graham Capital Management, L.P. Rapt Therapeutics, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 94,680 shares of RAPT stock, worth $184,626. This represents 0.01% of its overall portfolio holdings.
Number of Shares
94,680
Previous 23,310
306.18%
Holding current value
$184,626
Previous $209,000
37.8%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
125Shares Held
29.1MCall Options Held
905KPut Options Held
592K-
Vanguard Group Inc Valley Forge, PA3.11MShares$6.06 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$5.23 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$4.76 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$3.36 Million0.61% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$3.12 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $57.8M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...